Restart Life Sciences Corp. is a biotechnology company, which engages in the research and development of psilocybin. It offers therapy and diagnostics for neuroinflammatory disorders. The company was founded on October 27, 2004 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Restart Life Sciences Corp. market cap is $3.96M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Restart Life Sciences Corp. 52 week high is $0.1242 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Restart Life Sciences Corp. 52 week low is $0.0101 as of November 18, 2026.
Restart Life Sciences Corp. stock price today is $0.0633.
Restart Life Sciences Corp. stock price yesterday was $0.0153.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Restart Life Sciences Corp.'s P/E ratio is -2.79.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Restart Life Sciences Corp. P/B ratio is 4.2285.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Restart Life Sciences Corp. 50-day moving average is $0.0397.